Startseite>>Lipids>> Prostaglandins>>11-deoxy-11-methylene-15-keto Prostaglandin D2

11-deoxy-11-methylene-15-keto Prostaglandin D2 (Synonyms: 11deoxy11methylene15keto PGD2)

Katalog-Nr.GC41879

Prostaglandin D2 (PGD2) is one of the five primary enzymatic prostaglandins derived directly from PGH2.

Products are for research use only. Not for human use. We do not sell to patients.

11-deoxy-11-methylene-15-keto Prostaglandin D2 Chemische Struktur

Cas No.: 958759-75-6

Größe Preis Lagerbestand Menge
100μg
82,00 $
Auf Lager
500μg
371,00 $
Auf Lager
1mg
658,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Prostaglandin D2 (PGD2) is one of the five primary enzymatic prostaglandins derived directly from PGH2. Many of the biological effects of PGD2 are transduced in vivo by a classical 7-transmembrane GPCR, the DP1 receptor. However, a second receptor, the chemokine-related CRTH2 receptor, also binds PGD2. This new receptor was recently identified on human eosinophils, where it binds selectively the PGD2 metabolite 13,14-dihydro-15-keto PGD2. 11-deoxy-11-methylene-15-keto PGD2 was prepared as a more chemically stable ligand for this receptor. There are no published studies of the pharmacological properties of 11-deoxy-11-methylene-15-keto PGD2.

Bewertungen

Review for 11-deoxy-11-methylene-15-keto Prostaglandin D2

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 11-deoxy-11-methylene-15-keto Prostaglandin D2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.